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Crystal structureGolgi-Associated Plant Pathogenesis-Related protein 1 (GAPR-1) is a mammalian protein that belongs to the su-
perfamily of plant pathogenesis related proteins group 1 (PR-1). GAPR-1 is a peripheral membrane-binding pro-
tein that strongly associates with lipid-enrichedmicrodomains at the cytosolic leaﬂet of Golgi membranes. Little
is known about themechanism of GAPR‐1 interactionwithmembranes.We previously suggested that dimeriza-
tion plays a role in the function of GAPR‐1 and here we report that phytic acid (inositol hexakisphosphate) in-
duces dimerization of GAPR‐1 in solution. Elucidation of the crystal structure of GAPR‐1 in the presence of
phytic acid revealed that the GAPR‐1 dimer differs from the previously published GAPR‐1 dimer structure. In
this structure, one of the monomeric subunits of the crystallographic dimer is rotated by 28.5°. To study the
GAPR‐1 dimerization properties, we investigated the interaction with liposomes in a light scattering assay and
by ﬂow cytometry. In the presence of negatively charged lipids, GAPR‐1 caused a rapid and stable tethering of
liposomes. [D81K]GAPR‐1, amutant predicted to stabilize the IP6‐induced dimer conformation, also caused teth-
ering of liposomes. [A68K]GAPR‐1 however, amutant predicted to stabilize the non‐rotated dimer conformation,
is capable of binding to liposomes but did not cause liposome tethering. Our combined data suggest that the
charge properties of the lipid bilayer can regulate GAPR‐1 dynamics as a potential mechanism to modulate
GAPR‐1 function.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
Golgi-Associated plant Pathogenesis-Related protein 1 (GAPR-1)
is a mammalian protein, which is a member of the plant pathogenesis
related proteins group 1 (PR-1) superfamily. In plants, PR-1 proteins are
upregulated and secreted upon infection and are further characterized
by their relatively small molecular mass (14–17 kDa), often acidic or
basic nature, and resistance to proteases [1]. Proteins of this family are
related to each other based on sequence homology as well as tertiary
structure [2,3]. The mammalian PR-1 family member GAPR-1 is highly
expressed in immune-related tissues and cells [4]. Therefore, GAPR-1
may play a role in the innate immune system of mammals. The activity
and biological function of GAPR-1 and other PR-1 family members re-
main unknown. Although an anti-fungal activity has been described [5]+31 30 2535492.
/ Dr. Aiguader, 88, Barcelona,
500 Gilman Drive, Stein clinical
rights reserved.other publications report a serine protease activity [6]. The highly con-
served histidine and glutamate pairs of the PR-1 family have also been
proposed to represent a catalytic tetrad, although the arrangement
showed no similarities to any previously characterized enzymes [7,8].
We recently suggested that a catalytic triad similar to that of serine pro-
teases may be formed across the dimer interface by residues from both
molecules within the dimer [3], implying that dimer dynamics may reg-
ulate the activity of the protein.
In contrast to other known PR-1 family members, GAPR-1 is not
secreted, but localizes to the cytosolic leaﬂet of the Golgi membrane
[4]. GAPR-1 is strongly bound to Golgi membranes, as salt-stripping of
membranes or treatment of cells with Brefeldin A, which causes a redis-
tribution of GAPR-1 in cells, do not release GAPR-1 frommembranes [4].
GAPR-1 is myristoylated and fatty acid modiﬁcation could provide a
mechanism to anchor this protein to themembrane. The binding energy
ofmyristate incorporation into lipid bilayers is however not sufﬁcient to
stably anchor a protein to a membrane [9]. In support of this, several
myristoylated proteins do not show exclusive membrane localization
and a second interaction is required for efﬁcient membrane binding
(reviewed in [10,11]). GAPR-1 has a pI of 9.4 and therefore GAPR-1 is
predicted to have a net positive charge at physiological pH. According
to the crystal structure of GAPR-1, several positive charges localize to
one protein surface area [3], providing a possibility for efﬁcient
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in the membrane. Indeed, we recently described the binding of GAPR-1
to negatively charged lipids in vitro [12]. Furthermore, GAPR-1 has been
shown to interact with caveolin-1, and interactions with other proteins
are possible via a coiled-coil domain [3,4]. Finally, GAPR-1 has
been reported to interact with itself, forming homo-dimers [3,4].
Myristoylation, together with protein–protein interactions and/or elec-
trostatic interactionsmay be sufﬁcient for the stablemembrane binding
of GAPR-1.
Here we provide evidence for an additional level of regulation of
GAPR-1 dynamics at biological membranes. We report that GAPR-1
can adopt a different dimer conﬁguration in the presence of phytic
acid (inositol hexakisphosphate). Phytic acid (IP6) has been shown
to act as a cofactor of proteins [13–15] or to promote protein oligo-
merization [16,17]. Our results do not indicate a structural resem-
blance with these proteins. Rather, we favor the suggestion that the
electrostatic interaction of GAPR-1 with phytic acid may resemble
an electrostatic interaction of GAPR-1 with other negatively charged
structures such as negatively charged lipid bilayers. Hence, the charge
properties of lipid bilayers could potentially affect the dimerization
dynamics of GAPR-1.2. Materials and methods
2.1. Reagents
1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC), L-a-
phosphatidylinositol (bovine liver) and cholesterol were purchased
from Avanti Polar Lipids. Phytic acid (inositol hexakisphosphate, IP6)
(Cat. no. P8810) and lysozyme from chicken egg white (Cat. no.
L6876) were purchased from Sigma (St. Louis, US) and myo-inositol
fromGIBCO (Grand Island, US). 100 mM IP6 stock solutionswere fresh-
ly prepared in water and adjusted to neutral pH. Malonate-imidazol
boric acid (MIB), malic acid 2-(N-morpholino)ethanesulfonic acid
tris(hydroxymethyl)aminomethane (MMT) were purchased from Mo-
lecular Dimensions (Suffolk, UK) and poly(ethylene glycol) (PEG)
from Sigma (St. Louis, US).2.2. Plasmids
pQE60-GAPR-1 WT and pQE60-GAPR-1 Δ4 plasmids were de-
scribed previously [3,18]. [A68K]GAPR-1, [D81K]GAPR-1 and the
GAPR-1 lysine mutant were generated by site-directed mutagenesis
using polymerase chain reaction (PCR) on the pQE60-GAPR-1 WT
plasmid. The following mutagenic primers were used with the chan-
ged codons depicted in bold: 5′-gtgtggggagaaccttaaatgggcatcctatgatc-
3′ as the sense primer and 5′-gatcataggatgcccatttaaggttctccccacac-3′
as the antisense primer for the generation of [A68K]GAPR-1; 5′-
ggaaaggaggtggctaagagatggtacagtgaa-3′ as the sense primer and 5′-
ttcactgtaccatctcttagccacctcctttcc-3′ as the antisense primer for the gen-
eration of [D81K]GAPR-1. The GAPR-1 lysine mutant was generated in 4
steps: K7S, K53S, K88S and ΔK153-K154. The following mutagenic
primers were used: 5′-gggcaagtcagcttccagtcagtttcataatgagg-3′ and 5′-
cctcattatgaaactgactggaagctgacttgccc-3′ for K7S, 5′-cacgaggatcctcag-
tcacagcccggagtc-3′ and 5′-gactccgggctgtgactgaggatcctcgtg-3′ for K53S,
5′-gatggtacagtgaaatcagtaactataacttccagcagcc-3′ and 5′-ggctgctggaagt-
tatagttactgatttcactgtaccatc-3′ for K88S and 5′-cgtcctgccgccgtagaagtaact-
tgttaaatg-3′ and 5′-catttaacaagttacttctacggcggcaggacg-3′ for ΔK143–
K154. Reactions were performed using Pfu polymerase (Fermentas,
Burlington, Canada). The mutated DNA was selected by restriction-site
analysis, transformed into Escherichia coli (XL-1 blue, Stratagene, Cedar
Creek, US), and subsequently ampliﬁed using standardmolecular biolog-
ical techniques. The resulting plasmids were veriﬁed by sequencing
(Baseclear, Leiden, The Netherlands).2.3. Protein puriﬁcation
For the isolation of both wild type and mutant GAPR-1, a short-
ened protocol was used as described [18]. Brieﬂy, Escherichia coli
(XL-1 blue, Stratagene) were transformed with the pQE60-GAPR-1
WT, pQE60-[A68K]GAPR-1, pQE60-[D81K]GAPR-1 or GAPR-1 lysine
mutant plasmid. While shaking at 300 rpm, bacterial cultures were
induced with 1 mM IPTG for 4 h, 37 °C. After incubation the bacteria
were pelleted, washed twice in 50-NT buffer (50 mM NaCl, 25 mM
Tris pH 7.4), and homogenized by sonication. The homogenate was
cleared by centrifugation for 30 minutes at 14,000 rpm and by subse-
quent passage through a ﬁlter with 20 μm pore size. The soluble pro-
tein fraction was passed through a cation exchange column using SP
Triacryl Plus M. The column was then washed with 50-NT buffer
and GAPR-1 (WT or mutant) was eluted from the column with
350 mM NaCl, 25 mM Tris pH 7.4. The purity of the isolated proteins
was conﬁrmed by SDS-PAGE and Coomassie Blue staining.
2.4. Crystal structure determination
GAPR-1 was puriﬁed as described [3,18]. To crystallize GAPR-1 in
the presence of IP6, 11 mg GAPR-1 (1 mg/ml in 10 mM Tris, 50 mM
NaCl, pH 7.4) was incubated for 30 minutes at 37 °C in the presence
of IP6 (0.7 mM). GAPR-1 was concentrated by use of a spin column
(5 kDa cut-off ﬁlter) (Vivascience, Hannover, Germany) in a cooled
centrifuge to a ﬁnal concentration of 9.6 mg/ml, corresponding to
0.56 mM. Besides GAPR-1, the protein solution contained 50 mM
NaCl, 10 mM Tris pH 7.4 and 0.7 mM IP6. Initial crystallization screen-
ing was performed at room temperature by sitting-drop vapor-
diffusion. A HoneyBee 961 (Genomic Solutions) crystallization robot
was used for pipetting 50 μl of the reservoir solution into the wells
and for combining 150 nl protein solution and 150 nl reservoir solu-
tion. The initial block-shaped crystals were reproduced and opti-
mized by equilibration of 1+1 μl hanging drops. Crystals were
obtained at various conditions from either 100 mM MIB-buffer,
MMT-buffer or tris(hydroxymethyl)aminomethane-buffer pH 6.5–
7.0 and either 15–25% (w/v) PEG 1500, PEG 3350 or PEG 6000. A crys-
tal with dimensions 0.12×0.04×0.03 mm, that was grown from
100 mM MMT-buffer pH 6.5 and 15% (w/v) PEG 3350, was soaked
for 1 minute in a 2‐μl cryoprotectant solution containing 22% (w/v)
PEG 1500, 100 mM MMT-buffer pH 6.75 and 20% (v/v) glycerol in
the presence of 5 mM IP6 and then picked up using a ﬁber loop
prior to ﬂash cooling of the crystal by immersion in liquid nitrogen.
A data set was collected at 100 K on a CCD detector (MAR Research)
at ID23-2 at the ESRF at a resolution to 1.5 Å. The wavelength used
was 0.8726 Å, the total oscillation was 90° with an 0.5° oscillation
step per diffraction frame. The crystal belongs to the orthorhombic
space group C2221 with unit cell dimensions a=44.1, b=64.9 and
c=103.1 Å. Data collection and processing statistics are given in
Table 1. The data were integrated with MOSFLM [19] and scaled
using SCALA [19]. The structure was determined by molecular re-
placement with Phaser [20]. The structure of GAPR-1 in the absence
of IP6 (Protein Data Bank entry 1SMB) [3] was used as search
model. Manual adjustments of the model were carried out with
COOT [21] and REFMAC5 [19] was used for subsequent reﬁnements.
The solvent content calculated was 41% (v/v) with a Vm value of
2.1 Å3/Da. The electron density for residues 4–152 was clearly inter-
pretable. Residual density at the C-terminus allowed elongation of
the polypeptide chain with residues Lys153 and Lys154. However,
Lys153 and Lys154 showed poor side-chain density. In addition
poor side-chain density was observed for Lys7, Lys33 and Lys88. At
the interface of 4 crystallographic symmetry-related GAPR-1 mole-
cules the Fo−Fc difference map indicated an area of positive electron
density (≥ 3.5-6σ) that was surrounded by several positively charged
residues. The density showed features of IP6, but disorder was appar-
ent. We decided to model IP6 in the density map at half occupancy
Table 1
Data collection and reﬁnement statistics for GAPR-1 with phytic acid.
Data collection
Space group C2221
Cell dimensions
a, b, c (Å)
44.1, 64.9, 103.1
Resolution (Å) 22–1.5 (1.58–1.5)
Rmerge (%) 8.5 (43.3)
I /σI 9.9 (3.4)
Completeness (%) 91.8 (94.7)
Redundancy 4.0 (3.8)
Unique reﬂections 21759 (3260)
Mosaicity (º) 0.45
Reﬁnement
Resolution (Å) 36–1.5 (1.54–1.5)
No. reﬂections 20632 (1552)
No. free-R reﬂections (5.1%) 1116
Rwork / Rfree (%) 15.2 (20.1)/18.7 (25.5)
No. atoms
Residues
Phytic acid
Waters
1434
1225
36
173
Average B-factors (Å2)
all
Protein
Phytic acid
Water
10.1
7.9
40.8
19.4
R.m.s. deviations
Bond lengths (Å)
Bond angles (°)
0.022
1.83
Total No. residues 151
Double conformations Ser43, Ser48, Ser58, Ser71, Met107,
Met115, Ser121, Ser127
Restrained reﬁnement weighting factor 2.0
TLS group deﬁnitions (residue numbers) 4–32, 33–72, 73–103, 104–154
Values in parentheses refer to the highest resolution shell.
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ingly, despite co-crystallization of GAPR-1 in excess of IP6 and
soaking of crystals in excess IP6 (5 mM; data not shown), the incor-
poration of IP6 did not improve. In accordance with the structure
from Protein Data Bank entry 1SMB, a cysteinesulfonic acid residue
at residue 32 was assigned. However, the density for residue 63 un-
ambiguously indicated a cysteine, and not a cysteinesulfonic acid res-
idue as in 1SMB. The ﬁnal model contained 151 amino acid residues
(residues 4–154) corresponding to one monomer of GAPR-1 and
173 water molecules in the asymmetric unit. In total 8 residues
have been modeled in two equal populated independent conforma-
tions in accordance with the observed electron densities. The ﬁnal re-
ﬁned model, achieved after several cycles of reﬁnement using
REFMAC5 with the application of 4 consecutive TLS groups, had an
R factor and an Rfree of 15.2% and 18.7%, respectively. The stereochem-
istry displayed by the Ramachandran plot shows that 97.7% of the res-
idues fall in the most favored region and 2.3% in the additional
allowed region. Statistics on the model quality are given in Table 1.
All molecular graphics ﬁgures were generated with pymol (W. Dela-
no; http://www.pymol.org/). Coordinates and structure factors have
been deposited in the Protein Databank Bank (accession No. 4AIW).
2.5. Liposome binding assay
The liposome binding assay was performed as described [12]. In
short: Stock solutions of lipids were made in chloroform:methanol
(1:2) and stored at −20 °C under N2 atmosphere. Liposomes were
made freshly for each liposome binding assay. To generate liposomes,
phosphatidylcholine, phosphatidylinositol and cholesterol were mixed
from stock solutions at a molar ratio of 1.82:0.46:1 or at a ratio as indi-
cated in the ﬁgure legend. The solvents were evaporated using a ﬂow ofN2 with subsequent drying at room temperature in a Speedvac (Savant
SVC100H Farmingdale, US) for at least 90 minutes. 50-NT buffer was
added to the dried lipid ﬁlm to a ﬁnal phospholipid concentration of
17 mM. The tube was vortexed at least 3 times for 15 seconds until all
lipids had been suspended. To create liposomes, the lipid suspension
was sonicated 4 times for 15 seconds on ice using an ultrasonic probe
(MSE Soniprep 150, London, UK). The liposomes were relatively uni-
form in size (90–120 nm)with an average size of 100 nmas determined
by nano particle tracking analysis (NanoSight Ltd., Salisbury, United
Kingdom).
In a typical experiment, 20 μg recombinant GAPR-1, 100 μg bovine
serum albumin (BSA) (Roche, Basel, Switzerland) as carrier protein,
20 μl of the liposome mixture, and the indicated concentrations of IP6
were incubated in 50-NT buffer (90 μl total volume) for 90 minutes at
37 °C. The incubations were stopped by cooling the samples on ice. Su-
crose (60% (w/v) in 50-NT) was mixed with the samples to a ﬁnal con-
centration of 36.5% (w/v) sucrose. The samples were overlayed with
500 μl 25% (w/v) sucrose in 50-NT buffer and subsequently with 100 μl
50-NT buffer and centrifuged in a TLA-55 rotor (Beckman, Fullerton,
US) for 90 minutes at 55,000 rpm, 4 °C. After centrifugation, protein
bound to liposomes was collected in 300 μl from the top of the gradient.2.6. Gel ﬁltration
Dimerization of GAPR-1 or GAPR-1:IP6 complexes was determined
by gel ﬁltration. Brieﬂy, a 30/10 Pharmacia column containing Superdex
200 (Pharmacia, Uppsala, Sweden) was equilibrated with 50-NT buffer
(50 mM NaCl, 25 mM Tris pH 7.4). To estimate the size of the GAPR-1-
complexes, myoglobulin (18 kDa), ovalbumin (45 kDa), bovine serum
albumin (67 kDa) and bacitracin (1.4 kDa) were used as reference pro-
teins (ICN Biomedicals, Aurora, US). GAPR-1 was incubated in 50-NT
buffer with or without 1 mM IP6 in 100 μl total volume for 30 minutes
at 37 °C. The protein solution was then cooled to 4 °C, after which it
was loaded on the column and eluted at 0.5 ml/min at 4 °C. The eluent
was collected in fractions of 0.5 ml. The protein content of the fractions
was determined by absorbance at 280 nm. Elution of GAPR-1was deter-
mined byWestern blotting using a polyclonal GAPR-1 antibody [4]. Elu-
tion of IP6 wasmeasured by phosphate determination using a modiﬁed
spectrophotometric protocol according to Rouser [22]. Brieﬂy, 400 μl of
each fraction was taken and water was evaporated by heating. The res-
idue was resuspended in 150 μl 70% perchloric acid and heated to
180 °C for 1 h. Samples were cooled and then incubated with 625 μl
H2O, 125 μl 2.5% ammoniumheptamolybdate and 125 μl 10% (w/v)
ascorbic acid at 55 °C for 20 minutes. Absorbance of the samples was
measured at 820 nm wavelength and compared with that of standard
solutions of IP6.2.7. Gel electrophoresis
Proteins were resolved on 14% polyacrylamide gels. Gels were ana-
lyzed by staining with Coomassie Blue R250 (Serva Electrophoresis,
Heidelberg, Germany) or byWestern blotting. In the case of Coomassie
Blue staining, protein amounts were determined by optical scanning of
the Coomassie Blue-stained bands and analysis by use of Quantity One
software (Biorad, Hercules, US). The binding of GAPR-1 to liposomes
in the absence of IP6 was used as a reference (100%). For Western blot-
ting, an afﬁnity-puriﬁed polyclonal rabbit antibody against GAPR-1 was
used as described [4]. Peroxidase-labeled goat anti-rabbit (Nordic Im-
munology, Tilburg, The Netherlands) was used as secondary antibody.
Supersignal West Pico Chemiluminescent was purchased from Pierce
(Rockford, US). Chemiluminescence was captured with a Chemidox
XRS camera (Biorad) and signals were quantiﬁed using Quantity One
software package (Biorad). Signals from the incubations were com-
pared to standard curves with known amounts of GAPR-1.
AB
C
Fig. 1. Membrane binding of GAPR-1 is inhibited by phytic acid. A. Competition assay for
GAPR‐1 binding to PI‐containing liposomes. To generate liposomes, phosphatidylcholine,
phosphatidylinositol and cholesterol were mixed from stock solutions at a molar ratio of
1.94:0.34:1. GAPR‐1 (lane 4, ¼ of input) was incubated with liposomes (containing PI,
POPC and cholesterol), bovine serum albumin (BSA) (carrier protein) and buffer in the ab-
sence (lane 1) or presence of 5 mM inositol (lane 2) or 5 mM IP6 (lane 3) for 90minutes at
37 °C. After ﬂotation on a sucrose gradient, proteins bound to liposomes were resolved by
SDS‐PAGE and stained with Coomassie Blue. B. Titration of IP6. IP6 was titrated
(0–3000 μM) in the liposome binding as described for (A). Proteins bound to liposomes
were resolved by SDS‐PAGE and stained with Coomassie Blue. The insert shows a typical
experiment over the entire range of titration. To determine half‐maximal inhibition, the
intensity of the Coomassie Blue‐stained bands were quantiﬁed by optical scanning and
plotted as binding percentage relative to the binding in the absence of IP6. Bars represent
the standard deviation. C. Gel‐ﬁltration chromatography of GAPR‐1WT in the absence and
presence of IP6. GAPR‐1 (40 μg)was incubated in buffer in the absence (gray line) or pres-
ence (black line) of 1 mM IP6 for 30 minutes at 37 °C. The samples were resolved by gel‐
ﬁltration chromatography and eluted proteins were detected by UV absorption. To cali-
brate the column, ovalbumin, BSA, myoglobin, chymotrypsin, and bacitracin were used
as reference proteins.
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The turbidimetric method was originally developed by Bangham
et al. to determine the osmotic behavior of the multilamellar lipo-
somes [23]. This principle also allows analysis of clustering of lipo-
somes [24]. The turbidity of the liposome suspension was measured
at a wavelength of 600 nm using an Eppendorf Biophotometer and a
10 mm path length UVette® (Eppendorf, Hamburg, Germany). A typ-
ical reaction mixture consisted of 10 μl GAPR-1, 20 μl liposome mix-
ture (prepared as described earlier) in 50-NT buffer in a ﬁnal
volume of 90 μl. First, the OD of the liposome suspension was mea-
sured, after which the protein was added. After brief mixing the OD
was monitored in time.
2.9. Flow cytometric analysis
For ﬂow cytometry, liposomes were prepared as described above,
except that lipid ﬁlms were hydrated in the presence of 3 mM calcein
in 50-NT. Following sonication, non-encapsulated calcein was re-
moved by size-exclusion chromatography (Sephadex G-50, ﬁne)
using 50-NT as elution buffer.
To analyze the ~100 nm sized ﬂuorescently-labeled liposomes, we
used a recently developed ﬂow cytometry-based method for multi-
parameter analysis of individual nano-sized particles [25]. For these
measurements, the BD Inﬂux™ ﬂow cytometer (Becton Dickinson)
was triggered on the ﬂuorescence signal derived from the ﬂuorescently
labeled liposomes and thresholding was applied on this ﬂuorescence
channel. Fluorescence thresholding was based on measuring 0.22 μm
ﬁltered PBS, allowing an event rate of not more than 6 events per sec-
ond. Light scattering detection was performed in log mode. Samples
were measured at event rates lower than 10,000 events per second.
Typical reaction mixtures were appropriately diluted in 50-NT buffer
immediately before ﬂow cytometric analysis.
3. Results
3.1. Phytic acid inhibits binding of GAPR-1 to phosphatidylinositol
To investigate the contribution of lipids to GAPR-1 membrane
binding, a liposome binding assay was performed which showed
that GAPR-1 binds to phosphatidylinositol (PI) but not to phosphati-
dylcholine (PC) [12]. A systematic screen of potential effectors of
the GAPR-1 liposome binding assay was performed. After incuba-
tion, the liposome-bound GAPR-1 was ﬂoated on a sucrose gradient
and liposome-bound proteins in the top fraction were quantiﬁed.
When GAPR-1 was incubated with PI-containing liposomes for 90
minutes at 37 °C, approximately 20% of GAPR-1 bound to liposomes
(Fig. 1A). This is in agreement with previous observations [12].
When GAPR-1 was incubated with the liposomes in presence of
myo-inositol or meso-inositol, the binding of GAPR-1 to the lipo-
somes was not affected. However, when the incubation was per-
formed in presence of phytic acid (IP6, inositol hexakisphosphate),
the binding to liposomes was strongly reduced (Fig. 1A). Quantiﬁca-
tion of GAPR-1 binding efﬁciency at various concentrations of IP6
showed half maximal inhibition of GAPR-1 binding at 50–60 μM
IP6 (Fig. 1B).
3.2. Phytic acid induces dimerization of GAPR-1
IP6 is known to promote oligomerization of arrestin-2 and
trimerization of the HIV Gag protein [16,17]. Interestingly, dimeriza-
tion has been implicated in the function of GAPR-1 [3]. Therefore,
we investigated whether GAPR-1 also dimerizes or oligomerizes in
the presence of IP6. To test this, GAPR-1 was incubated in the absence
or presence of IP6 and the size of the GAPR-1 complex was estimated
by gel ﬁltration chromatography. In the absence of IP6, GAPR-1 elutedfrom the column as a protein with an apparent molecular mass of
10 kDa (Fig. 1C). When incubated with IP6, GAPR-1 migrated faster
on the column, with an apparent molecular mass of 20 kDa. This indi-
cates that IP6 promotes dimerization of GAPR-1. To exclude a formal
possibility that the shift from 10 kDa to 20 kDa is caused by non-
speciﬁc electrostatic binding of a large number (15 molecules of IP6
Fig. 2. Superposition of GAPR-1 dimer structures in the absence and presence of IP6. The
monomeric structures are superimposed using residues 4–152. The left monomers
(yellow) are positioned in the same orientation to allow visualization of the rotation of
the partner monomers at the right (partner monomer of the open dimer structure in the
presence of IP6 in red). For structural visualization of the GAPR‐1 dimer in the absence of
IP6, Protein Data Bank entry 1SMB was used.
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ometry of the IP6-GAPR-1 interaction was determined by measuring
the phosphate and protein content in the eluted fractions of the gel-
ﬁltration experiments. In the peak fraction approximately a 1:1 ratio
of protein:IP6 was found, demonstrating that the shift of IP6-bound
GAPR-1 is not caused by binding multiple IP6 molecules to GAPR-1.
3.3. The crystal structure of the GAPR-1 dimer in the presence of phytic
acid shows rotation of GAPR-1 monomers
We performed X-ray crystallography to determine the effect of IP6
on the GAPR-1 dimer structure. Comparing the structures of the mono-
meric subunits in the absence and presence of IP6 resulted in a r.m.s. ﬁt
for 149 aligned Cα positions of 0.47 Å, indicating a good structural
agreement between GAPR-1 monomers in the absence or presence ofK53
A68
H103
F128
Open dimer
Fig. 3. Interface of the open and closed GAPR-1 dimer conﬁgurations. Dimers in the presence
of the dimers. IP6 is omitted from the ﬁgure in the left panel. The monomers of the crystallo
representation is shown in cyan and the involved residues of the dimeric partner molecule
Trp69, Ser71, Tyr72, Arg82, Glu86, Ser99 and Gly100) are colored magenta and are unlabele
His54, Lys77, Glu78, Asp81, Ser85, Lys88 and Asn89; open dimer‐interface additional residu
both panels, the left monomer (yellow) is positioned in the same orientation to allow visua
idues within contact distance of 4 Å observed at the dimer interface in both structures are
resulting in a small extended structure (left panel, near the bottom of the left (yellow) moIP6 (Suppl. Fig. 1). In the presence of IP6, one of themonomeric subunits
of the crystallographic dimer is rotated by 28.5°, relative to the previ-
ously reported GAPR-1 dimer structure, which was determined in the
absence of IP6 [3] (Fig. 2). As a consequence of the rearrangement the
interface between theGAPR-1monomers has become smaller, resulting
in a more open dimeric structure (Fig. 3). Hereafter we will refer to the
rotated dimer structure in the presence of IP6 as ‘open dimer', and the
dimer structure in the absence of IP6 as 'closed dimer'. In the closed
dimer structure, the interface area of the dimer calculated by PISA
[26] was 943 Å2 (11.7%) and for the open dimer structure in presence
of IP6 717 Å2 (8.6%).
A signiﬁcant difference between both dimer interfaces is a predom-
inant hydrophilic patch formed by residues 77–89 in the closed dimer
interface that is lacking in the open dimer interface (Fig. 3). There is
also a major change in orientation of the side chain of residue Lys88,
resulting in an entire opening of the cleft in the open dimer. The closed
dimer has a single salt bridge between Lys88 and Asp81 of the partner
monomer, whereas the open dimer has a salt bridge between Arg50
and Leu52 across the dimer interface.
Due to reorientation of the monomers, the putative catalytic triad,
consisting of His54, Glu65 and a symmetry-related Ser71 [3], formed
across the dimer interface by residues from both molecules within the
dimer, is disrupted. The distance between His54 Nε2 and Ser71 Oγ of
the partner monomer is signiﬁcantly changed from 4.2 Å to 5.7 Å in
the presence of IP6; with all intramolecular distances of the putative
catalytic residues being the same.
The position of IP6 in the open structure could not be unambiguously
determined. It was possible, however, tomodel IP6 in the Fo-Fc difference
map. An additional buried-surface area of 269 Å2 was calculated with
PISA for IP6 inwhich IP6 is surrounded by several positively charged res-
idues belonging to different GAPR-1 molecules. In this model, residues
that make a putative salt bridge with IP6 are Lys7 and Lys33 (molecule
1), Lys53 (molecule 2), Lys88 and Lys154 (molecule 3), and Arg50 (mol-
ecule 4). Of these residues Lys33 and Lys88 are further away from IP6,
but could possibly contribute additionally to the ligand binding site
(Suppl. Fig. 2). However, mutation of Lys7, Lys53 and Lys88 to serine
and deletion of Lys153 and Lys154 using site directed mutagenesis did
not affect the inhibition of GAPR-1 membrane-binding by IP6 and IP6
still caused dimerization (Suppl. Fig. 3). This suggests that the modelingH54
Y20
E78
K77
S85
K88
N89
D81
Closed dimer
(left panel) or absence (right panel) of IP6, showing the relative rotation of the subunits
graphic dimers are packed face‐to‐face. At the interfacial region the molecular surface
are indicated as sticks. Common dimer‐interface residues (Arg50, Ile51, Leu52, Leu67,
d, the other additional residues (closed dimer‐interface additional residues are Tyr20,
es are Lys53, Ala68, His103 and Phe128) are colored orange and labeled accordingly. In
lization of the rotation of the partner monomer (right monomer in both panels). Res-
shown. Of note, in the presence of IP6, residues Lys153 and Lys154 could be assigned,
nomer).
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of IP6 was based on the identiﬁcation of an area with positive electron
density (≥ 3.5-6σ) with features of IP6, but disorder was apparent (see
Materials and methods). Thus, although we do not doubt the location
of IP6 in the crystal structure, alternative IP6 orientations may be
possible.3.4. Inhibition ofmembrane binding is not dependent on dimer conﬁguration
To investigate the potential signiﬁcance of the IP6-induced rotation
in the dimer, GAPR-1 mutants were designed to stabilize different
dimer conﬁgurations. Alanine 68 (A68) is involved in stabilization of
the open (rotated) dimer (Fig. 3). When A68 is replaced by lysine, rota-
tion of GAPR-1monomers relative to each other in the dimerwill not be
favorable, as the lysine is in close proximity of a tryptophan residue
(W69) of the other monomer. By contrast, aspartic acid 81 (D81) is a
prominent amino acid involved in the stabilization of the closed confor-
mation by interaction with lysine 88 (Fig. 3) in the opposite facing
monomer.WhenD81 is replaced by lysine, ionic repulsionmay destabi-
lize the closed conformation. To test whether [A68K]GAPR-1 and
[D81K]GAPR-1 mutants are still able to interact with IP6, the behavior
of these mutants were analyzed by gel ﬁltration chromatography
(Fig. 4A). When [A68K]GAPR-1 was incubated with IP6, a shift in
apparent molecular mass was observed that closely resembled the
shift described above for wild type GAPR-1 in the presence of IP6
(Fig. 1C), indicating that [A68K]GAPR-1 mutant is able to interact
with IP6. Similar results were obtained for [D81K]GAPR-1 (data not
shown). As GAPR-1 wild type forms the open dimer conformation in
the presence of IP6, thismay indicate that the open dimer conformation
is favorable in the presence of IP6 under normal circumstances.
To investigate whether the IP6-induced rotation is the cause of the
observed inhibition of membrane binding of GAPR-1, a liposome
binding experiment was performed with the [A68K]GAPR-1 and
[D81K]GAPR-1 mutants in presence or absence of IP6. As shown in
Fig. 4B, both mutants bind efﬁciently to liposomes and the bindingA
B
Fig. 4. Phytic acid induces dimer formation and inhibits membrane binding of [A68K]
GAPR-1 and [D81K]GAPR-1. A. Gel‐ﬁltration chromatography of [A68K]GAPR‐1
(40 μg) in the absence (gray line) and presence (black line) of 1 mM IP6. B. Competi-
tion assay for GAPR‐1 binding to PI liposomes. GAPR‐1 WT, [A68K]GAPR‐1 and
[D81K]GAPR‐1 were incubated with liposomes in the absence or presence of 1 mM
IP6 for 90 minutes at 37 °C. GAPR‐1 binding to liposomes was analyzed by SDS‐PAGE
(upper panel). Shown is a representative experiment (n=3).of both mutants is inhibited by IP6. Thus, inhibition of membrane
binding is not dependent on a particular dimer conﬁguration.
3.5. GAPR-1 membrane-binding causes dimerization
Our observations raise the question how IP6 inhibits membrane
binding of GAPR-1 to negatively charged liposomes. The ﬁrst possibility
is that dimerization per se inhibits membrane binding. This seems un-
likely as GAPR-1 dimers have been identiﬁed on isolated Golgi mem-
branes [4]. The second possibility is that IP6 resembles some
properties (charge and/or structure) of the lipid bilayer and competes
with membranes for interaction with GAPR-1. A consequence of the
IP6-mimicking properties of membranes is that it would predict dimer-
ization of GAPR-1 upon membrane-binding. To investigate this, we
employed an assay that measures clustering of liposomes by light scat-
tering [23,24]. Liposome-bound GAPR-1 may bring together liposomes
upon dimerization, resulting in increased particle sizes, which in turn
causes increased light scatter and absorbance. Liposomes of different
composition were incubated with GAPR-1 WT or mutant proteins at
room temperature and the clustering of liposomes was determined by
measuring the absorbance of the incubation at 600 nm. As shown in
Fig. 5A, addition of GAPR-1 wild type to liposomes results in a rapid in-
crease in light scattering. The increased absorbance remains stable for at
least 60 minutes, indicating that a steady state level has been reached.
Similar results were obtained with [D81K]GAPR-1 mutant, butFig. 5.WTGAPR-1 causes liposome clustering, which is dependent on the dimer conforma-
tion. Light scattering assay. Optical density (λ=600 nm) of liposome suspension is moni-
tored in time, following the addition of GAPR‐1 WT, [A68K]GAPR‐1 and [D81K]GAPR‐1,
respectively. Panel A: At t=0, protein was added to a suspension of PC/PI/cholesterol lipo-
somes (molar ratio 1.82:0.46:1) in 50‐NT buffer, in the absence or presence of IP6 (1 mM);
Panel B: At t=0, protein was added to a suspension of PC/cholesterol liposomes (molar
ratio 2.28:1) in 50‐NT buffer.
Fig. 6. WT and [D81K]GAPR-1 clustering of liposomes is driven by electrostatic interac-
tions. A. Temperature dependence of light scattering changes upon addition of GAPR‐1
to liposomes. Optical density (λ=600 nm) of liposome suspension is monitored during
incubation with GAPR‐1 WT or [A68K]GAPR‐1 at either 4 °C or 37 °C. A representative
chart is shown (n=3). B. Sensitivity of increased light scattering towards high salt con-
centration. PC/PI/cholesterol liposomes were incubated with [A68K] or [D81K]GAPR‐1
for 60 minutes at 37 °C and the increase in light scattering as compared to liposomes in
the absence of protein (ΔOD) was determined (black bars). NaCl was then added to a
ﬁnal concentration of 500 mM (grey bars). A representative chart is shown (n=3).
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not result in an increase in light scattering for 20minutes, with a subse-
quent slow but steady increase of light scattering. The question arises
whether this is caused by a difference in dimer conformation on the
membrane or perhaps merely by slower binding kinetics of the A68K
mutant. The overall binding kinetics of [A68K]GAPR-1 mutant were,
however, shown to be identical to that of GAPR-1 WT (Fig. 4B and
data not shown). This rules out the possibility that the absence of a
rapid increase in light scattering for [A68K]GAPR-1 is due to a lack of
binding. Therefore, these results show that the assay is capable of
measuring differences in light scattering between different GAPR-1
mutants representing the open and closed dimer conﬁguration.
In agreement with our hypothesis that IP6 mimics some properties
of membranes, we found that addition of IP6 also effectively inhibits
the increase of particle size in the light scattering assay (Fig. 5A). WeFig. 7. GAPR-1 induces tethering of liposomes. Liposomes ﬂuorescently labeled with calcein w
ﬂuorescence. Shown are dot plots of FSC versus calcein ﬂuorescence representing control l
with GAPR‐1 and IP6 (right). Numbers indicate the percentage of events in the upper rightobtained similar results with phosphatidic acid-containing liposomes
(data not shown). This suggests that the interaction of GAPR-1 with
negatively charged PI liposomes is based on electrostatic forces that
are effectively disrupted by IP6. In the absence of negatively charged
lipids, GAPR-1 does not induce light scattering (Fig. 5B).
The aberrant kinetics of [A68K]GAPR-1mutantwere further investi-
gated by incubation at 4 °C and 37 °C. As shown in Fig. 6A, the slow and
steady increase of light scattering caused by [A68K]GAPR-1 mutant is
temperature dependent. No increase in scattering is observed after pro-
longed incubation at 4 °C, whereas the kinetics of tethering induced by
GAPR-1 wild type is temperature independent. This may suggest that
the observed increase in light scattering caused by [A68K]GAPR-1 mu-
tant is not solely based on ionic interactions. In agreement with this
suggestion, we found that the increased light scattering caused by pro-
longed incubation with [A68K]GAPR-1 is insensitive to high salt con-
centrations, whereas for [D81K]GAPR-1 and wild-type the increase in
optical density is reversible at any time point by the addition of
500 mM NaCl (Fig. 6B). Further support comes from the observation
that IP6 is a less effective inhibitor of this A68Kmutant in the light scat-
tering assay (Fig. 5A).
3.6. GAPR-1 induces tethering of liposomes
The interaction of GAPR-1with liposomes was further analyzed by a
high resolution ﬂow cytometry-based method, which was recently de-
veloped to characterize individual particles with sizes that fall below
the detection limit of conventional ﬂow cytometers (300 nm) [25].
The ~100 nm sized liposomes could be observed above the ﬂuorescence
threshold (Fig. 7). In the absence of GAPR-1, calcein-loaded liposomes
appeared as a relatively homogeneous population based on forward
light scatter (FSC) and calcein signals. Addition of GAPR-1 caused a
shift in light scatter (FSC) as well as in ﬂuorescence of a distinct subset
of events (Fig. 7). The concomitant increase of ﬂuorescence with parti-
cle size has several implications as i) it rules out the possibility that
GAPR-1 forms large aggregates on a single liposome causing an increase
in scattering but not ﬂuorescence; and ii) the liposomes with increased
scatter remain sealed and do not release their soluble luminal ﬂuores-
cent dye which would cause a non-linear increase in ﬂuorescence
with increasing scatter. The GAPR-1 induced clustering of liposomes is
fully reversible as subsequent treatment with IP6 restored the ﬂuores-
cent characteristics resembling the original liposome population
(Fig. 7). This demonstrates that GAPR-1 induced clustering of liposomes
reﬂects a tethering rather than a fusion process.
GAPR-1 dimerization between liposomes is expected to compete
with GAPR-1 dimerization on individual liposomes. This may explain
the fact that only a subset of liposomes clusters and GAPR-1 is not capa-
ble of clustering all liposomes. To test this further, we determined the
dependency of tethering on GAPR-1 concentration. At high concentra-
tions of GAPR-1, more GAPR-1 is expected to bind to liposomes [12]ere visualized by high‐resolution ﬂow cytometric analysis using a threshold on calcein
iposomes (left), liposomes incubated with GAPR‐1 (middle) and liposomes incubated
quadrant, representing clustered liposomes.
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and reducing the formation of dimers between liposomes. Indeed,
with increasing concentrations of GAPR-1 the tethering decreased
again. As a control we incubated the same liposomes with lysozyme,
which is similar in size and charge to GAPR-1 and known to cause ag-
gregation and fusion of liposomes [27]. In contrast to GAPR-1, lysozyme
induced a concentration-dependent but continuously increasing signal
in light scattering with increasing concentrations of lysozyme (Fig. 8).
4. Discussion
4.1. GAPR-1 dimerization
GAPR-1 has a tendency to form homo-dimers. Aminority (9%) of sol-
uble recombinant non-myristoylated GAPR-1 is dimerized in vitro.
Crosslinking experiments showed that GAPR-1 forms homo-dimers on
membranes [3]. In addition, GAPR-1 crystallizes as a dimer [3]. GAPR-1
in vivo can also form homo-dimers, as GAPR-1 interacts with itself in a
yeast 2-hybrid system [3]. We now report that GAPR-1 dimerizes in
the presence of IP6. Oligomerization by IP6 has been observed for other
proteins as well. The HIV-1 protein Gag is in a monomer-dimer equi-
librium and in the presence of IP6 this equilibrium shifts towards
monomer–trimer [16]. Another example of a protein that is oligomerized
by IP6 is arrestin-2, a regulator of G-coupled receptors [17]. In the case of
arrestin-2, a high and lowafﬁnity binding site for IP6was identiﬁed in the
crystal structure. Binding of IP6 to arrestin-2 did not cause a signiﬁcant
global conformational change or rearrangement [17]. Crystal structure
analysis of individual GAPR-1 monomers also did not show any
major conformational change in the presence of IP6. The 3D model
of IP6-treated GAPR-1 shows however that one of the monomeric
subunits of the GAPR-1 dimer is rotated by 28.5° in the dimer conﬁgu-
ration, relative to the previously reported dimer conﬁguration.
To determine the effect of this rotation on the GAPR-1 binding prop-
erties, we generated an [A68K]GAPR-1 mutant in which the rotation of
the dimer is destabilized to favor the closed conformation, and a [D81K]
GAPR-1 mutant which favors the open dimer conformation. By light
scattering we were able to demonstrate that only the open conforma-
tion supports tethering of lipid bilayers.
4.2. GAPR-1 and phytic acid
In cells, IP6 has been reported as a cofactor for the yeast RNA
editing enzyme ADAR2, for the plant Fbox protein TIR1 and for the
mammalian autocatalytic cleavage of Toxin B from Clostridium difﬁcile
[13–15]. It is possible that IP6 is a cofactor for GAPR-1 as well. Dimer-
ization of GAPR-1 results in the formation of a putative catalytic triadFig. 8. Tethering of liposomes is dependent on the ratio of GAPR-1 and negatively
charged lipids in liposomes. Changes in optical density of liposome suspensions by
the addition of increasing amounts of GAPR‐1 WT and lysozyme, respectively. Protein
was added in the indicated amounts to a PC/PI/cholesterol (1.82:0.46:1) liposome sus-
pension in 50‐NT buffer (ﬁnal phospholipid concentration 3,78 mM). Each measure-
ment was performed 1 minute after adding the protein and it was veriﬁed that the
OD remained subsequently stable.[3]. Rotation of the dimer by IP6 may disrupt the catalytic triad, neg-
atively regulating e.g. the putative serine protease activity of GAPR-1.
IP6 competes for membrane binding of GAPR-1 in the micromolar
range. This is within the range of physiological IP6 concentrations of
mammalian cells (10–100 μM) [28–30]. Therefore, variations of cyto-
solic IP6 concentrations may have a direct effect on GAPR-1 dynamics
and function.
By gel ﬁltrationwe show that treatment of GAPR-1with IP6 results in
the formation of a stable dimer of GAPR-1. The orientation of IP6 in the
open structure could, however, not be unambiguously determined. At-
tempts to co-crystallize GAPR-1 in excess of IP6 and soaking of crystals
in excess IP6 did not improve the electron density for IP6. An area of pos-
itive electron density was observed at the interface of 4 symmetry-
related GAPR-1 molecules that was surrounded by several positively
charged residues. The density showed features of IP6, but disorder was
apparent. IP6 was modeled in the density map and included in the re-
ﬁnement. The putative GAPR-1 binding site for IP6 was compared with
other known IP6-interacting proteins. Currently, the PDB contains 34
ﬁleswith IP6 (deﬁned as IHP). TIR1 domains bind IP6with the surround-
ing basic residues mainly oriented towards the equatorial phosphate
groups [15]. This domain lacks structural resemblance with GAPR-1.
Non-TIR1 PDB ﬁles showdiversemanners of IP6 binding. A common fea-
ture for all of these sites is a large number (ranging from 5 to 10) of argi-
nines, lysines and sometimes histidines surrounding IP6. A similar
surrounding was suggested for the IP6 binding pocket in GAPR-1. How-
ever, simultaneous mutation of 5 positively charged amino acids at the
proposed interface with IP6 did not affect inhibition of membrane-
binding by IP6 and IP6 still caused dimerization.
We consider it likely that the interaction of GAPR-1 with IP6 mimics
an electrostatic interaction with other negatively charged structures,
possibly negatively charged lipid bilayers. This would explain the com-
petition of IP6 with negatively charged bilayers in the binding assay.
Other negatively charged biomolecules such as 2,3 bisphosphoglycerate
or inorganic phosphate were, however, much less effective inhibitors of
GAPR-1 binding to negatively charged liposomes. These compounds did
not affect the GAPR-1 binding assay up to 50-mM. Thus, some structural
features of IP6 such as negative charge-density play a role in the inhib-
itory effect.
4.3. GAPR-1 dynamics and implications
We favor a model in which GAPR-1 monomers are in a dynamic
equilibrium with GAPR-1 dimers. This has already been demonstrated
for GAPR-1 in solution. Isolation of the dimeric GAPR-1 results in
reappearance of monomeric GAPR-1 [3]. Our results now suggest that
upon binding to negative charges, GAPR-1 shifts the equilibrium to a
particular dimer conﬁguration. Depending on the charge-density, the
monomeric subunits of the dimer may be induced to rotate and form
an alternative dimeric structure with distinct membrane-binding and
tethering properties. It remains to be established whether there is an
equilibrium between the open and closed GAPR-1 dimer conﬁguration,
but it is tempting to speculate that regulation of the negative charge of a
membrane dictates the equilibriumbetween the open and closed dimer
conﬁguration. The binding properties of the closed dimer ([A68K]
GAPR-1) are different from the open dimer ([D81K]GAPR-1) conﬁgura-
tion. The interaction of [A68K]GAPR-1 mutant with liposomes is tem-
perature dependent and slow as compared to [D81K]GAPR-1 mutant.
This indicates that the interaction of [A68K]GAPR-1 mutant with nega-
tively charged lipid bilayers is not entirely electrostatic. Hydrophobic
interactions may also be involved in the interaction of [A68K]GAPR-1
mutant with membranes, e.g. by partial insertion into the lipid bilayer.
This has been suggested for other myristoylated proteins such as ARF
and MARCKS proteins [31].
Thus, dynamics of GAPR-1 dimerization is a novelmembrane-binding
and conformation determinant that may act synergistically with other
known membrane binding determinants such as myristoylation and
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teractions with lipid membranes are in principle sufﬁcient to affect
GAPR-1 dynamics. This offers potential application to other family mem-
bers. GAPR-1 belongs to the superfamily of PR-1 proteins and all other
familymembers are secreted as non-myristoylatedproteins. In the extra-
cellular space, PR-1 proteins are suggested to interact with the plasma
membrane and with pathogens [1]. Both these surfaces are highly nega-
tively charged allowing optimal interaction with the basic members of
the PR-1 superfamily. Future investigations will indicate whether these
interactions are involved in the regulation PR-1 protein dynamics.
Supplementary materials related to this article can be found on-
line at http://dx.doi.org/10.1016/j.bbamem.2012.04.016.Abbreviations
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